Amrinone
Drug Status in Canada : Approved
Indication : Why is this medication prescribed?
Congestive heart failure.
Contraindication: What are the special precautions to be followed?
Under following conditions, use of this medication is inadvisable. Its use should be withhold as it would cause harm to the patient
Hypersensitivity.Other Precaution to be observed while taking this medication
Obstructive pulmonary or aortic disease. Hypertrophic cardiomyopathy. Pregnancy and lactation.
What are possible side effects of this medication ?
Cardiac arrhythmia, hepatotoxicity. G.I. disturbances, myositis nail discoloration, nausea, hypersensitivity, vomiting, thrombocytopenia, chest pain, hypotension, vasculitis, decreased tear production.
Drug Category/Class
- Phosphodiesterase Inhibitors
- Cardiotonic Agents
- Phosphodiesterase 3 Inhibitors
- Calcium Channel Blockers
- Cardiovascular System
- Cardiac Therapy
- Cardiac Stimulants Excl. Cardiac Glycosides
- Vasodilator Agents
- Phosphodiesterase inhibitors
Prescribed | Used in the treatment of congestive heart failure. |
Weight : | 187.198 |
Structure | Amrinone |
|
Formula | C10H9N3O |
Amrinone has 3 Brands listed
Search Generic Drugs alphabetically